{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T19:36:46Z","timestamp":1792870606247,"version":"4.5.0"},"reference-count":212,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":1558,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1038\/ki.2011.223","type":"journal-article","created":{"date-parts":[[2011,7,13]],"date-time":"2011-07-13T11:04:02Z","timestamp":1310555042000},"page":"572-586","source":"Crossref","is-referenced-by-count":783,"title":["Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)"],"prefix":"10.1016","volume":"80","author":[{"given":"Charles A.","family":"Herzog","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Asinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan K.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Charytan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"D\u00edez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Uwe","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertram L.","family":"Kasiske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rod S.","family":"Passman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie S.","family":"DeLoach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick H.","family":"Pun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberhard","family":"Ritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2011.223_bb0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/j.ajkd.2009.06.034","article-title":"Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: the Hisayama study","volume":"55","author":"Nakano","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2011.223_bb0015","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000111829","article-title":"Chronic kidney disease is associated with angiographic coronary artery disease","volume":"28","author":"Chonchol","year":"2008","journal-title":"Am J Nephrol"},{"key":"10.1038\/ki.2011.223_bb0020","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1097\/01.ASN.0000095642.25603.7A","article-title":"Association between renal insufficiency and inducible ischemia in patients with coronary artery disease: the heart and soul study","volume":"14","author":"Ix","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.223_bb0025","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00007890-199001000-00022","article-title":"Ineffectiveness of dipyridamole SPECT thallium imaging as a screening technique for coronary artery disease in patients with end-stage renal failure","volume":"49","author":"Marwick","year":"1990","journal-title":"Transplantation"},{"key":"10.1038\/ki.2011.223_bb0030","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/ndt\/12.4.718","article-title":"Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease","volume":"12","author":"Joki","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2011.223_bb0035","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1681\/ASN.2004090765","article-title":"High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination","volume":"16","author":"Ohtake","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.223_bb0040","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/jama.290.3.353","article-title":"Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis","volume":"290","author":"deFilippi","year":"2003","journal-title":"JAMA"},{"key":"10.1038\/ki.2011.223_bb0045","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.jacc.2003.06.001","article-title":"Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality","volume":"42","author":"Gibson","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1038\/ki.2011.223_bb0050","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7326\/0003-4819-137-7-200210010-00006","article-title":"Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients","volume":"137","author":"Shlipak","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1038\/ki.2011.223_bb0055","doi-asserted-by":"crossref","first-page":"563","DOI":"10.7326\/0003-4819-137-7-200210010-00007","article-title":"Acute myocardial infarction and renal dysfunction: a high-risk combination","volume":"137","author":"Wright","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1038\/ki.2011.223_bb0060","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1161\/01.CIR.0000027560.41358.B3","article-title":"Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes","volume":"106","author":"Al","year":"2002","journal-title":"Circulaton"},{"key":"10.1038\/ki.2011.223_bb0065","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJMoa041365","article-title":"Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction","volume":"351","author":"Anavekar","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2011.223_bb0070","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2011.223_bb0075","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"key":"10.1038\/ki.2011.223_bb0080","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJM199809173391203","article-title":"Poor long-term survival after acute myocardial infarction among patients on long-term dialysis","volume":"339","author":"Herzog","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2011.223_bb0085","series-title":"USRDS 2008 Annual Data Report: Atlas of Chronic Kidney Disease & End-Stage Renal Disease in the United States","author":"US Renal Data System","year":"2008"},{"key":"10.1038\/ki.2011.223_bb0090","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1097\/01.ASN.0000019641.41496.1E","article-title":"Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study","volume":"13","author":"Longenecker","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.223_bb0095","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jacc.2007.03.037","article-title":"The Framingham predictive instrument in chronic kidney disease","volume":"50","author":"Weiner","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1038\/ki.2011.223_bb0100","first-page":"221","article-title":"Are conventional cardiovascular risk factors predictive of two-year mortality in hemodialysis patients?","volume":"56","author":"Fleischmann","year":"2001","journal-title":"Clin Nephrol"},{"key":"10.1038\/ki.2011.223_bb0105","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1523-1755.2003.00803.x","article-title":"Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients","volume":"63","author":"Kalantar-Zadeh","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.223_bb0110","doi-asserted-by":"crossref","first-page":"4D","DOI":"10.1016\/j.amjcard.2008.02.002","article-title":"Anti-inflammatory agents and antioxidants as a possible \u2018third great wave\u2019 in cardiovascular secondary prevention","volume":"101","author":"Bhatt","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1038\/ki.2011.223_bb0115","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/ki.2008.75","article-title":"Inflammation and cardiovascular events in individuals with and without chronic kidney disease","volume":"73","author":"Weiner","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.223_bb0120","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1523-1755.2005.00455.x","article-title":"C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease","volume":"68","author":"Menon","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.223_bb0125","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/ndt\/18.1.106","article-title":"Homocysteine, C-reactive protein, lipid peroxidation and mortality in haemodialysis patients","volume":"18","author":"Bayes","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2011.223_bb0130","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrneph.2010.30","article-title":"Aldosterone: effects on the kidney and cardiovascular system","volume":"6","author":"Briet","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"10.1038\/ki.2011.223_bb0135","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1001\/archinte.168.11.1174","article-title":"25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study","volume":"168","author":"Giovannucci","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1038\/ki.2011.223_bb0140","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archinternmed.2007.110","article-title":"Association of activated vitamin D treatment and mortality in chronic kidney disease","volume":"168","author":"Kovesdy","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1038\/ki.2011.223_bb0145","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2011.223_bb0150","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/ajkd.2001.20584","article-title":"Informational contribution of noninvasive screening tests for coronary artery disease in patients on chronic renal replacement therapy","volume":"37","author":"Schmidt","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2011.223_bb0155","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2174\/157340309788970342","article-title":"Coronary risk assessment and management options in chronic kidney disease patients prior to kidney transplantation","volume":"5","author":"Karthikeyan","year":"2009","journal-title":"Curr Cardiol Rev"},{"key":"10.1038\/ki.2011.223_rf0160","first-page":"e525","volume":"122","author":"Taylor","year":"2010","journal-title":"Circulation"},{"key":"10.1038\/ki.2011.223_bb0165","first-page":"e561","volume":"119","author":"Hendel","year":"2009","journal-title":"Circulation"},{"key":"10.1038\/ki.2011.223_bb0170","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1097\/00007890-199611150-00008","article-title":"Evaluation of diabetic patients for renal and pancreas transplantation: noninvasive screening for coronary artery disease using radionuclide methods","volume":"62","author":"Vandenberg","year":"1996","journal-title":"Transplantation"},{"key":"10.1038\/ki.2011.223_bb0175","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.amjcard.2007.03.057","article-title":"Usefulness of stress echocardiography for risk stratification and prognosis of patients with left ventricular hypertrophy","volume":"100","author":"Bangalore","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1038\/ki.2011.223_bb0180","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0735-1097(02)02105-8","article-title":"Influence of wall stress and left ventricular geometry on the accuracy of dobutamine stress echocardiography","volume":"40","author":"Yuda","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1038\/ki.2011.223_bb0185","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0272-6386(99)70145-9","article-title":"Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates","volume":"33","author":"Herzog","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2011.223_bb0190","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/MCA.0b013e32832ac5eb","article-title":"The diagnostic and prognostic value of tissue Doppler imaging during dobutamine stress echocardiography in end-stage renal disease","volume":"20","author":"Sharma","year":"2009","journal-title":"Coron Artery Dis"},{"key":"10.1038\/ki.2011.223_bb0195","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/CIRCULATIONAHA.107.696765","article-title":"Clinical characteristics of dialysis patients with acute myocardial infarction in the United States: a collaborative project of the United States Renal Data System and the National Registry of Myocardial Infarction","volume":"116","author":"Herzog","year":"2007","journal-title":"Circulation"},{"key":"10.1038\/ki.2011.223_bb0200","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1053\/j.ajkd.2005.11.017","article-title":"Differential symptoms of acute myocardial infarction in patients with kidney disease: a community-wide perspective","volume":"47","author":"Sosnov","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2011.223_bb0205","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0735-1097(02)02608-6","article-title":"Cardiac troponins in renal insufficiency: review and clinical implications","volume":"40","author":"Freda","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1038\/ki.2011.223_bb0210","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chronic renal disease","volume":"32","author":"Foley","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2011.223_bb0215","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1525-139X.2007.00335.x","article-title":"Reverse epidemiology in patients with chronic kidney disease who are not yet on dialysis","volume":"20","author":"Kovesdy","year":"2007","journal-title":"Semin Dial"},{"key":"10.1038\/ki.2011.223_bb0220","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/01.HYP.0000154895.18269.67","article-title":"Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions","volume":"45","author":"Kalantar-Zadeh","year":"2005","journal-title":"Hypertension"},{"key":"10.1038\/ki.2011.223_bb0225","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1038\/sj.ki.5001934","article-title":"The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease","volume":"70","author":"Charytan","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.223_bb0230","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/jama.296.11.1377","article-title":"Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease","volume":"296","author":"Coca","year":"2006","journal-title":"JAMA"},{"key":"10.1038\/ki.2011.223_bb0235","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2215\/CJN.09301209","article-title":"Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analyses","volume":"5","author":"Williams","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.223_bb0240","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1053\/j.ajkd.2009.12.038","article-title":"Glycemic control and the risk of death in 1,484 patients receiving maintenance hemodialysis","volume":"55","author":"Shurraw","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2011.223_bb0245","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1523-1755.1998.00005.x","article-title":"\u2018U\u2019 curve association of blood pressure and mortality in hemodialysis patients","volume":"54","author":"Zager","year":"1998","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.223_bb0250","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1161\/HYPERTENSIONAHA.109.144899","article-title":"Blood pressure and mortality among hemodialysis patients","volume":"55","author":"Agarwal","year":"2010","journal-title":"Hypertension"},{"key":"10.1038\/ki.2011.223_bb0255","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ahj.2005.06.017","article-title":"Increased targeting of cardiovascular risk factors in patients with chronic kidney disease does not improve atheroma burden or cardiovascular function","volume":"151","author":"Isbel","year":"2006","journal-title":"Am Heart J"},{"key":"10.1038\/ki.2011.223_bb0260","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jacc.2010.02.068","article-title":"Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trial","volume":"56","author":"Jardine","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1038\/ki.2011.223_bb0265","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Antithrombotic Trialists\u2019 Collaboration","year":"2002","journal-title":"BMJ"},{"key":"10.1038\/ki.2011.223_bb0270","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/01.CIR.0000143892.84582.60","article-title":"Effect of pravastatin on cardiovascular events in people with chronic kidney disease","volume":"110","author":"Tonelli","year":"2004","journal-title":"Circulation"},{"key":"10.1038\/ki.2011.223_bb0275","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2011.223_bb0280","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstrom","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2011.223_bb0285","series-title":"Should We Reduce LDL Cholesterol in Patients with Chronic Kidney Disease? The Results of the Study of Heart and Renal Protection (SHARP)","author":"The SHARP Collaborative Group","year":"2010"},{"key":"10.1038\/ki.2011.223_bb0290","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/01.hjr.0000220582.19516.a6","article-title":"Renal function and outcomes in acute coronary syndrome: impact of clopidogrel","volume":"14","author":"Keltai","year":"2007","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1038\/ki.2011.223_bb0295","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0735-1097(03)00572-2","article-title":"Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction","volume":"42","author":"Berger","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1038\/ki.2011.223_bb0300","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1001\/jama.2009.1800","article-title":"Contraindicated medication use in dialysis patients undergoing percutaneous coronary intervention","volume":"302","author":"Tsai","year":"2009","journal-title":"JAMA"},{"key":"10.1038\/ki.2011.223_bb0305","doi-asserted-by":"crossref","first-page":"179","DOI":"10.47102\/annals-acadmedsg.V39N3p179","article-title":"Reperfusion strategy and mortality in ST-elevation myocardial infarction among patients with and without impaired renal function","volume":"39","author":"Chan","year":"2010","journal-title":"Ann Acad Med Singapore"},{"key":"10.1038\/ki.2011.223_bb0310","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jacc.2006.06.050","article-title":"Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials","volume":"48","author":"Bavry","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1038\/ki.2011.223_bb0315","first-page":"e148","article-title":"ACC\/AHA 2007 guidelines for the management of patients with unstable angina\/non ST-elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"116","author":"Anderson","year":"2007","journal-title":"Circulation"},{"key":"10.1038\/ki.2011.223_bb0320","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.2215\/CJN.05551008","article-title":"Early angiography in patients with chronic kidney disease: a collaborative systematic review","volume":"4","author":"Charytan","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.223_bb0325","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/CIRCULATIONAHA.108.838169","volume":"120","author":"Szummer","year":"2009","journal-title":"Circulation"},{"key":"10.1038\/ki.2011.223_bb0330","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1161\/CIRCULATIONAHA.107.187930","volume":"116","author":"Fraker","year":"2007","journal-title":"Circulation"},{"key":"10.1038\/ki.2011.223_bb0335","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCULATIONAHA.107.188208","volume":"117","author":"King","year":"2008","journal-title":"Circulation"},{"key":"10.1038\/ki.2011.223_bb0340","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.amjcard.2009.07.043","article-title":"Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease","volume":"104","author":"Sedlis","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1038\/ki.2011.223_bb0345","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ahj.2004.10.010","article-title":"Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS)","volume":"149","author":"Ix","year":"2005","journal-title":"Am Heart J"},{"key":"10.1038\/ki.2011.223_bb0350","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1161\/01.CIR.102.24.2973","article-title":"Risks of morbidity and mortality in dialysis patients undergoing coronary artery bypass surgery","volume":"102","author":"Liu","year":"2000","journal-title":"Circulation"},{"key":"10.1038\/ki.2011.223_bb0355","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1093\/ndt\/gfl835","article-title":"Risks of coronary artery bypass surgery in dialysis-dependent patients\u2014analysis of the 2001 National Inpatient Sample","volume":"22","author":"Charytan","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2011.223_bb0360","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/CIRCULATIONAHA.105.580084","article-title":"Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database","volume":"113","author":"Cooper","year":"2006","journal-title":"Circulation"},{"key":"10.1038\/ki.2011.223_bb0365","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1161\/01.CIR.0000035248.71165.EB","article-title":"Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes","volume":"106","author":"Herzog","year":"2002","journal-title":"Circulation"},{"key":"10.1038\/ki.2011.223_rf0370","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1046\/j.1523-1755.2001.00799.x","article-title":"Differential survival after coronary revascularization procedures among patients with renal insufficiency","volume":"60","author":"Szczech","year":"2001","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.223_bb0375","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1253\/circj.CJ-08-1091","article-title":"Comparison of drug-eluting stents and coronary artery bypass grafting for the treatment of multivessel coronary artery disease in patients with chronic kidney disease","volume":"73","author":"Wang","year":"2009","journal-title":"Circ J"},{"key":"10.1038\/ki.2011.223_bb0380","first-page":"41A","article-title":"Long-term survival and repeat revascularization in U.S. dialysis patients after surgical versus percutaneous coronary intervention. [abstract]","volume":"20","author":"Herzog","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.223_bb0385","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/eurheartj\/ehp507","article-title":"Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative","volume":"31","author":"Ronco","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1038\/ki.2011.223_bb0390","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/ncpneph0673","article-title":"Cardiorenal versus renocardiac syndrome: is there a difference?","volume":"3","author":"Schrier","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1038\/ki.2011.223_bb0395","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/01.crd.0000148162.88296.9f","article-title":"Increased prevalence of coronary artery disease, silent myocardial ischemia, complex ventricular arrhythmias, atrial fibrillation, left ventricular hypertrophy, mitral annular calcium, and aortic valve calcium in patients with chronic renal insufficiency","volume":"14","author":"Das","year":"2006","journal-title":"Cardiol Rev"},{"key":"10.1038\/ki.2011.223_bb0400","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/ndt\/gfq066","article-title":"Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference","volume":"25","author":"Bagshaw","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2011.223_bb0405","series-title":"USRDS 2004 Annual Data Report","author":"US Renal Data System","year":"2004"},{"key":"10.1038\/ki.2011.223_bb0410","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.amjcard.2006.08.042","article-title":"Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study","volume":"99","author":"Ahmed","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1038\/ki.2011.223_bb0415","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/00041552-200411000-00003","article-title":"Cardiovascular disease in chronic kidney disease from a cardiologist's perspective","volume":"13","author":"McCullough","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1038\/ki.2011.223_bb0420","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11906-008-0021-2","article-title":"Arterial structure and function in end-stage renal disease","volume":"10","author":"Guerin","year":"2008","journal-title":"Curr Hypertens Rep"},{"key":"10.1038\/ki.2011.223_bb0425","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/HYPERTENSIONAHA.109.141275","article-title":"Reduced ascending aortic strain and distensibility: earliest manifestations of vascular aging in humans","volume":"55","author":"Redheuil","year":"2010","journal-title":"Hypertension"},{"key":"10.1038\/ki.2011.223_bb0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5301\/JN.2010.2030","article-title":"Epidemiology and pathophysiology of left ventricular abnormalities in chronic kidney disease: a review","volume":"24","author":"Cerasola","year":"2011","journal-title":"J Nephrol"},{"key":"10.1038\/ki.2011.223_bb0435","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1053\/j.ajkd.2010.01.023","article-title":"Emerging role of the bufadienolides in cardiovascular and kidney diseases","volume":"56","author":"Puschett","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2011.223_bb0440","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1038\/ki.2008.512","article-title":"Myocardial fibrosis in chronic kidney disease: potential benefits of torasemide","volume":"74","author":"Lopez","year":"2008","journal-title":"Kidney Int Suppl"},{"key":"10.1038\/ki.2011.223_bb0445","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ccl.2005.04.002","article-title":"Congestive heart failure in chronic kidney disease: disease-specific mechanisms of systolic and diastolic heart failure and management","volume":"23","author":"Curtis","year":"2005","journal-title":"Cardiol Clin"},{"key":"10.1038\/ki.2011.223_bb0450","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000245634","article-title":"Haemodialysis-induced myocardial stunning in chronic kidney disease\u2014a new aspect of cardiovascular disease","volume":"29","author":"McIntyre","year":"2010","journal-title":"Blood Purif"},{"key":"10.1038\/ki.2011.223_bb0455","doi-asserted-by":"crossref","first-page":"c242","DOI":"10.1159\/000276575","article-title":"Echocardiography in chronic kidney disease: diagnostic and prognostic implications","volume":"114","author":"Pecoits-Filho","year":"2010","journal-title":"Nephron Clin Pract"},{"key":"10.1038\/ki.2011.223_bb0460","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients","volume":"45","author":"National Kidney Foundation","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2011.223_bb0465","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1681\/ASN.V115912","article-title":"Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease","volume":"11","author":"Foley","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.223_bb0470","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/j.1523-1755.2004.00530.x","article-title":"Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression","volume":"65","author":"Zoccali","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.223_bb0475","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1253\/circj.CJ-10-0444","article-title":"Heart failure, chronic kidney disease, and biomarkers\u2014an integrated viewpoint","volume":"74","author":"Iwanaga","year":"2010","journal-title":"Circ J"},{"key":"10.1038\/ki.2011.223_bb0480","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1373\/clinchem.2007.095679","article-title":"National academy of clinical biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure","volume":"53","author":"Wu","year":"2007","journal-title":"Clin Chem"},{"key":"10.1038\/ki.2011.223_bb0485","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1258\/acb.2009.008213","article-title":"Serial increased cardiac troponin T predicts mortality in asymptomatic patients treated with chronic haemodialysis","volume":"46","author":"Roberts","year":"2009","journal-title":"Ann Clin Biochem"},{"key":"10.1038\/ki.2011.223_bb0490","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1161\/01.CIR.0000041254.30637.34","article-title":"Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease","volume":"106","author":"Apple","year":"2002","journal-title":"Circulation"},{"key":"10.1038\/ki.2011.223_bb0495","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1542-4758.2009.00377.x","article-title":"The relationship between laboratory-based outcome measures and mortality in end-stage renal disease: a systematic review","volume":"13","author":"Desai","year":"2009","journal-title":"Hemodial Int"},{"key":"10.1038\/ki.2011.223_bb0500","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1093\/eurheartj\/ehn309","volume":"29","author":"Dickstein","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1038\/ki.2011.223_bb0505","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/ndt\/gfq252","article-title":"ADQI 7: the clinical management of the Cardio-Renal syndromes: work group statements from the 7th ADQI consensus conference","volume":"25","author":"Davenport","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2011.223_bb0510","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.jacc.2010.03.105","article-title":"Effects of telmisartan added to angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebo-controlled trial","volume":"56","author":"Cice","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1038\/ki.2011.223_bb0515","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1388-9842(01)00174-X","article-title":"Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure","volume":"3","author":"Erdmann","year":"2001","journal-title":"Eur J Heart Fail"},{"key":"10.1038\/ki.2011.223_bb0520","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0735-1097(03)00241-9","article-title":"Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial","volume":"41","author":"Cice","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1038\/ki.2011.223_bb0525","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1525-1594.1993.tb03179.x","article-title":"Analysis of heart morphology and function following erythropoietin treatment of anemic dialysis patients","volume":"17","author":"Sikole","year":"1993","journal-title":"Artif Organs"},{"key":"10.1038\/ki.2011.223_bb0530","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2004121039","article-title":"Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease","volume":"16","author":"Parfrey","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.223_bb0535","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1681\/ASN.2009060631","article-title":"Left ventricular geometry predicts cardiovascular outcomes associated with anemia correction in CKD","volume":"20","author":"Eckardt","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.223_bb0540","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2011.223_bb0545","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"Correction of anemia with epoetin alfa in chronic kidney disease","volume":"355","author":"Singh","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2011.223_bb0550","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2011.223_bb0555","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.223_bb0560","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/sj.ki.5002518","article-title":"The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer","volume":"72","author":"Russo","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.223_bb0565","first-page":"S1","article-title":"KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"76","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1038\/ki.2011.223_bb0570","first-page":"CD006023","article-title":"Phosphate binders for preventing and treating bone disease in chronic kidney disease patients","volume":"2","author":"Navaneethan","year":"2011","journal-title":"Cochrane Database Systematic Review"},{"key":"10.1038\/ki.2011.223_bb0575","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1177\/039139880803100506","article-title":"The importance of dialysate sodium concentration in determining interdialytic weight gains in chronic hemodialysis patients: the PanThames Renal Audit","volume":"31","author":"Davenport","year":"2008","journal-title":"Int J Artif Organs"},{"key":"10.1038\/ki.2011.223_bb0580","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/089686080602600113","article-title":"Volume control associated with better cardiac function in long-term peritoneal dialysis patients","volume":"26","author":"Asci","year":"2006","journal-title":"Perit Dial Int"},{"key":"10.1038\/ki.2011.223_bb0585","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/ndt\/gfm549","article-title":"The relationship between the flow of arteriovenous fistula and cardiac output in haemodialysis patients","volume":"23","author":"Basile","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2011.223_bb0590","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1161\/CIRCULATIONAHA.109.886473","article-title":"Cardiorenal syndrome: new perspectives","volume":"121","author":"Bock","year":"2010","journal-title":"Circulation"},{"key":"10.1038\/ki.2011.223_bb0595","doi-asserted-by":"crossref","first-page":"c4249","DOI":"10.1136\/bmj.c4249","article-title":"Low glomerular filtration rate and risk of stroke: meta-analysis","volume":"341","author":"Lee","year":"2010","journal-title":"BMJ"},{"key":"10.1038\/ki.2011.223_bb0600","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1523-1755.2003.00101.x","article-title":"Elevated risk of stroke among patients with end-stage renal disease","volume":"64","author":"Seliger","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.223_rf0605","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1053\/j.ajkd.2009.01.261","article-title":"Cerebrovascular disease incidence, characteristics, and outcomes in patients initiating dialysis: the choices for healthy outcomes in caring for ESRD (CHOICE) study","volume":"54","author":"Sozio","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2011.223_bb0610","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1053\/j.ajkd.2005.02.028","article-title":"Stroke in patients on maintenance hemodialysis: a 22-year single-center study","volume":"45","author":"Toyoda","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2011.223_bb0615","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0140-6736(00)02783-5","article-title":"Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial","volume":"356","author":"Boaz","year":"2000","journal-title":"Lancet"},{"key":"10.1038\/ki.2011.223_bb0620","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000075776","article-title":"Incidence, etiology, and outcome of stroke in patients on continuous ambulatory peritoneal dialysis","volume":"17","author":"Toyoda","year":"2004","journal-title":"Cerebrovasc Dis"},{"key":"10.1038\/ki.2011.223_bb0625","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/STROKEAHA.108.520882","article-title":"Chronic kidney disease and clinical outcome in patients with acute stroke","volume":"40","author":"Yahalom","year":"2009","journal-title":"Stroke"},{"key":"10.1038\/ki.2011.223_bb0630","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/ki.2008.5","article-title":"Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: PROGRESS trial","volume":"73","author":"Ninomiya","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.223_bb0635","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1681\/ASN.2009030287","article-title":"Carotid endarterectomy benefits patients with CKD and symptomatic high-grade stenosis","volume":"21","author":"Mathew","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.223_bb0640","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0912321","article-title":"Stenting versus endarterectomy for treatment of carotid-artery stenosis","volume":"363","author":"Brott","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2011.223_bb0645","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0140-6736(10)61009-4","article-title":"Short-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis: a preplanned meta-analysis of individual patient data","volume":"376","author":"Bonati","year":"2010","journal-title":"Lancet"},{"key":"10.1038\/ki.2011.223_bb0650","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jvs.2005.10.069","article-title":"Defining the high-risk patient for carotid endarterectomy: an analysis of the prospective National Surgical Quality Improvement Program database","volume":"43","author":"Stoner","year":"2006","journal-title":"J Vasc Surg"},{"key":"10.1038\/ki.2011.223_bb0655","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/S10016-006-9080-5","article-title":"Chronic renal insufficiency and risk of early mortality in patients undergoing carotid endarterectomy","volume":"20","author":"Debing","year":"2006","journal-title":"Ann Vasc Surg"},{"key":"10.1038\/ki.2011.223_bb0660","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/ndt\/gfp619","article-title":"In-hospital outcomes with thrombolytic therapy in patients with renal dysfunction presenting with acute ischaemic stroke","volume":"25","author":"Agrawal","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2011.223_bb0665","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000097043","article-title":"Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ischemic stroke treated with recombinant tissue plasminogen activator outside clinical trials","volume":"23","author":"Marti-Fabregas","year":"2007","journal-title":"Cerebrovasc Dis"},{"key":"10.1038\/ki.2011.223_bb0670","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJM198204293061703","article-title":"Epidemiologic features of chronic atrial fibrillation: the Framingham study","volume":"306","author":"Kannel","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2011.223_bb0675","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/ki.2009.477","article-title":"Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy","volume":"77","author":"Wizemann","year":"2010","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.223_bb0680","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/CIRCULATIONAHA.108.816082","article-title":"Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study","volume":"119","author":"Go","year":"2009","journal-title":"Circulation"},{"key":"10.1038\/ki.2011.223_bb0685","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1038\/ki.2011.223_bb0690","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1161\/circ.114.4.257","volume":"114","author":"Fuster","year":"2006","journal-title":"Circulation"},{"key":"10.1038\/ki.2011.223_bb0695","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1525-139X.2002.00052.x","article-title":"Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment","volume":"15","author":"Wilmer","year":"2002","journal-title":"Semin Dial"},{"key":"10.1038\/ki.2011.223_bb0700","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1038\/ki.2011.223_bb0705","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1681\/ASN.2009030319","article-title":"Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation","volume":"20","author":"Chan","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.223_bb0710","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/ndt\/gfp589","article-title":"Outcome of atrial fibrillation among patients with end-stage renal disease","volume":"25","author":"Chou","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2011.223_bb0715","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/europace\/euq387","article-title":"Warfarin in haemodialysis patients with atrial fibrillation: what benefit?","volume":"12","author":"Yang","year":"2010","journal-title":"Europace"},{"key":"10.1038\/ki.2011.223_bb0720","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1038\/ki.2011.223_bb0725","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ahj.2005.04.017","article-title":"Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF)","volume":"151","author":"Gage","year":"2006","journal-title":"Am Heart J"},{"key":"10.1038\/ki.2011.223_bb0730","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1053\/j.ajkd.2007.06.017","article-title":"Warfarin anticoagulation in hemodialysis patients: a systematic review of bleeding rates","volume":"50","author":"Elliott","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2011.223_bb0735","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1681\/ASN.2008080824","article-title":"Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients","volume":"20","author":"Chan","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.223_bb0740","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1038\/ki.2011.223_bb0745","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1161\/CIRCULATIONAHA.109.853119","article-title":"New anticoagulants","volume":"121","author":"Eikelboom","year":"2010","journal-title":"Circulation"},{"key":"10.1038\/ki.2011.223_bb0750","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1056\/NEJMp0903763","article-title":"Left atrial appendage occlusion\u2014closure or just the beginning?","volume":"360","author":"Maisel","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2011.223_bb0755","series-title":"Paradaxa (package insert)","author":"Boehringer Ingelheim Pharmaceuticals I","year":"2010"},{"key":"10.1038\/ki.2011.223_bb0760","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2011.223_bb0765","series-title":"Advisory Committee Briefing Document: Dabigatran Etexilate (DE)","author":"Boehringer Ingelheim Pharmaceuticals I","year":"2010"},{"key":"10.1038\/ki.2011.223_bb0770","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/11318170-000000000-00000","article-title":"Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study","volume":"49","author":"Stangier","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"10.1038\/ki.2011.223_bb0775","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jacc.2010.12.013","article-title":"Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk","volume":"57","author":"Marinigh","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1038\/ki.2011.223_bb0780","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/01.CIR.0000114519.75433.DD","article-title":"High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999\u20132000","volume":"109","author":"O\u2019Hare","year":"2004","journal-title":"Circulation"},{"key":"10.1038\/ki.2011.223_bb0785","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2215\/CJN.00070109","article-title":"Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function","volume":"4","author":"Lash","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.223_bb0790","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1681\/ASN.V12122838","article-title":"Lower-extremity peripheral arterial disease among patients with end-stage renal disease","volume":"12","author":"O\u2019Hare","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.223_bb0795","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.2215\/CJN.00640109","article-title":"Key comorbid conditions that are predictive of survival among hemodialysis patients","volume":"4","author":"Miskulin","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.223_bb0800","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/01.ASN.0000119574.27772.FD","article-title":"Renal insufficiency and the risk of lower extremity peripheral arterial disease: results from the Heart and Estrogen\/Progestin Replacement Study (HERS)","volume":"15","author":"O\u2019Hare","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.223_bb0805","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1681\/ASN.V132497","article-title":"Peripheral vascular disease risk factors among patients undergoing hemodialysis","volume":"13","author":"O\u2019Hare","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.223_bb0810","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5414\/CNP63098","article-title":"Peripheral vascular disease and serum phosphorus in hemodialysis: a nested case-control study","volume":"63","author":"Boaz","year":"2005","journal-title":"Clin Nephrol"},{"key":"10.1038\/ki.2011.223_bb0815","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1053\/j.ajkd.2003.08.045","article-title":"Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD","volume":"43","author":"Cooper","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2011.223_bb0820","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0272-6386(99)70392-6","article-title":"Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease","volume":"34","author":"Manns","year":"1999","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 1","key":"10.1038\/ki.2011.223_bb0825","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1111\/j.1432-2277.1998.tb01098.x","article-title":"Peripheral arterial disease as a predictor of outcome after renal transplantation","volume":"11","author":"Makisalo","year":"1998","journal-title":"Transpl Int"},{"key":"10.1038\/ki.2011.223_bb0830","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.2215\/CJN.05761207","article-title":"Cilostazol improves long-term patency after percutaneous transluminal angioplasty in hemodialysis patients with peripheral artery disease","volume":"3","author":"Ishii","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.223_rf0835","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1540-8183.2010.00548.x","article-title":"Predictors of poor outcome in female patients undergoing endovascular intervention","volume":"23","author":"Abbas","year":"2010","journal-title":"J Interv Cardiol"},{"key":"10.1038\/ki.2011.223_bb0840","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1523-1755.2004.00420.x","article-title":"Predictors of amputation and survival following lower extremity revascularization in hemodialysis patients","volume":"65","author":"Jaar","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.223_bb0845","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0741-5214(96)70146-5","article-title":"Functional outcome after surgical treatment for intermittent claudication","volume":"24","author":"Zannetti","year":"1996","journal-title":"J Vasc Surg"},{"key":"10.1038\/ki.2011.223_bb0850","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/ajkd.2001.25194","article-title":"Long-term outcomes of revascularization for peripheral vascular disease in end-stage renal disease patients","volume":"38","author":"Reddan","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2011.223_bb0855","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1046\/j.1523-1755.1999.00668.x","article-title":"Nontraumatic lower extremity amputations in the Medicare end-stage renal disease population","volume":"56","author":"Eggers","year":"1999","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.223_bb0860","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.2337\/diacare.27.9.2198","article-title":"Diabetes is the strongest risk factor for lower-extremity amputation in new hemodialysis patients","volume":"27","author":"Speckman","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1038\/ki.2011.223_bb0865","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1097\/01.ASN.0000061776.60146.02","article-title":"Impact of renal insufficiency on short-term morbidity and mortality after lower extremity revascularization: data from the Department of Veterans Affairs\u2019 National Surgical Quality Improvement Program","volume":"14","author":"O\u2019Hare","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.223_bb0870","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1067\/mva.2002.128297","article-title":"A decade experience with infrainguinal revascularization in a dialysis-dependent patient population","volume":"36","author":"Ramdev","year":"2002","journal-title":"J Vasc Surg"},{"key":"10.1038\/ki.2011.223_bb0875","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2337\/diacare.23.9.1445","article-title":"Preventing amputations among patients with diabetes on dialysis","volume":"23","author":"Rith-Najarian","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1038\/ki.2011.223_bb0880","series-title":"Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine","article-title":"Cardiac arrest and sudden cardiac death","author":"Myerburg","year":"2005"},{"key":"10.1038\/ki.2011.223_bb0885","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1161\/01.CIR.93.3.519","article-title":"Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials","volume":"93","author":"Pratt","year":"1996","journal-title":"Circulation"},{"key":"10.1038\/ki.2011.223_bb0890","series-title":"USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States","first-page":"140","author":"US Renal Data System","year":"2005"},{"key":"10.1038\/ki.2011.223_bb0895","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2215\/CJN.01130307","article-title":"Can we prevent sudden cardiac death in dialysis patients?","volume":"2","author":"Herzog","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.223_bb0900","series-title":"USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease & End-Stage Renal Disease in the United States","author":"US Renal Data System","year":"2010"},{"key":"10.1038\/ki.2011.223_bb0905","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2215\/CJN.02360706","article-title":"Predictors of survival after cardiac arrest in outpatient hemodialysis clinics","volume":"2","author":"Pun","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.223_bb0910","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1523-1755.2001.00806.x","article-title":"Cardiac arrest and sudden death in dialysis units","volume":"60","author":"Karnik","year":"2001","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.223_bb0915","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1159\/000013500","article-title":"Clinical findings and outcomes of intra-hemodialysis cardiopulmonary resuscitation","volume":"19","author":"Lai","year":"1999","journal-title":"Am J Nephrol"},{"key":"10.1038\/ki.2011.223_bb0920","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1681\/ASN.V361238","article-title":"Outcomes of cardiopulmonary resuscitation in dialysis patients","volume":"3","author":"Moss","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.223_bb0925","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1056\/NEJMoa021583","article-title":"Effect of dialysis dose and membrane flux in maintenance hemodialysis","volume":"347","author":"Eknoyan","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2011.223_bb0930","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2011.223_bb0935","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/ki.2008.449","article-title":"The association of sudden cardiac death with inflammation and other traditional risk factors","volume":"74","author":"Parekh","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.223_bb0940","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/HYPERTENSIONAHA.110.151167","article-title":"Sudden cardiac death in end-stage renal disease patients: a 5-year prospective analysis","volume":"56","author":"Wang","year":"2010","journal-title":"Hypertension"},{"key":"10.1038\/ki.2011.223_bb0945","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.amjcard.2006.03.025","article-title":"Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction","volume":"98","author":"Goldenberg","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1038\/ki.2011.223_bb0950","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1161\/CIRCULATIONAHA.106.642892","article-title":"Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial","volume":"114","author":"Saxon","year":"2006","journal-title":"Circulation"},{"key":"10.1038\/ki.2011.223_bb0955","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/ki.2009.219","article-title":"Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease","volume":"76","author":"Pun","year":"2009","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.223_bb0960","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1161\/HYPERTENSIONAHA.107.103804","article-title":"Kidney dysfunction and sudden cardiac death among women with coronary heart disease","volume":"51","author":"Deo","year":"2008","journal-title":"Hypertension"},{"key":"10.1038\/ki.2011.223_bb0965","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/CIRCOUTCOMES.109.875369","article-title":"Cystatin C and sudden cardiac death risk in the elderly","volume":"3","author":"Deo","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1038\/ki.2011.223_bb0970","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMe078008","article-title":"Firefighting and death from cardiovascular causes","volume":"356","author":"Rosenstock","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2011.223_bb0975","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1525-139X.2008.00455.x","article-title":"Sudden cardiac death and dialysis patients","volume":"21","author":"Herzog","year":"2008","journal-title":"Semin Dialysis"},{"key":"10.1038\/ki.2011.223_bb0980","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1681\/ASN.V1071606","article-title":"The clinical epidemiology of cardiac disease in chronic renal failure","volume":"10","author":"Parfrey","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.223_bb0985","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/ndt\/12.5.952","article-title":"Sudden death in chronic dialysis patients","volume":"12","author":"Takeda","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2011.223_bb0990","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1056\/NEJMra000650","article-title":"Sudden death due to cardiac arrhythmias","volume":"345","author":"Huikuri","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2011.223_bb0995","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1038\/sj.ki.5000446","article-title":"Characteristics of sudden death in hemodialysis patients","volume":"69","author":"Bleyer","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.223_bb1000","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/sj.ki.5002749","article-title":"Outcome of cardiac arrests attended by emergency medical services staff at community outpatient dialysis centers","volume":"73","author":"Davis","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.223_bb1005","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/ndt\/gfk007","article-title":"Predictors and outcome of cardiopulmonary resuscitation (CPR) calls in a large haemodialysis unit over a seven-year period","volume":"21","author":"Lafrance","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2011.223_bb1010","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1046\/j.1523-1755.1999.00391.x","article-title":"Sudden and cardiac death rates in hemodialysis patients","volume":"55","author":"Bleyer","year":"1999","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.223_bb1015","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/ki.2010.315","article-title":"Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics","volume":"79","author":"Pun","year":"2011","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.223_bb1020","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0002-9343(89)90301-X","article-title":"Sleep apnea syndrome in chronic renal disease","volume":"86","author":"Kimmel","year":"1989","journal-title":"Am J Med"},{"key":"10.1038\/ki.2011.223_bb1025","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1681\/ASN.V133729","article-title":"Nocturnal hypoxemia predicts incident cardiovascular complications in dialysis patients","volume":"13","author":"Zoccali","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.223_bb1030","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/ndt\/gfh288","article-title":"The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey","volume":"19","author":"Paoletti","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2011.223_bb1035","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/ki.2009.200","article-title":"Changes in adiponectin and the risk of sudden death, stroke, myocardial infarction, and mortality in hemodialysis patients","volume":"76","author":"Drechsler","year":"2009","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.223_bb1040","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1681\/ASN.2009101047","article-title":"Digoxin associates with mortality in ESRD","volume":"21","author":"Chan","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.223_bb1045","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0085-2538(15)50904-6","article-title":"Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators","volume":"68","author":"Herzog","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.223_bb1050","series-title":"Am J Kidney Dis","article-title":"Trends in the use and outcomes of implantable cardioverter defibrillators in patients undergoing dialysis in the United States","author":"Charytan","year":"2011"},{"key":"10.1038\/ki.2011.223_bb1055","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1053\/j.ajkd.2007.02.272","article-title":"Increased complication rates of cardiac rhythm management devices in ESRD patients","volume":"49","author":"Dasgupta","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2011.223_bb1060","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.hrthm.2009.08.006","article-title":"Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation","volume":"6","author":"Aggarwal","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1038\/ki.2011.223_bb1065","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(11)60101-3","article-title":"Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial","volume":"377","author":"Abraham","year":"2011","journal-title":"Lancet"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815551053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815551053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T23:22:00Z","timestamp":1686180120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815551053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":212,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0085253815551053"],"URL":"https:\/\/doi.org\/10.1038\/ki.2011.223","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}